• China First Capital Group appointed Gu Xingchen as executive director and deputy CEO, effective Sept. 7, 2026.
• Role centers on debt restructuring, investment inflows, financing, client relationship management, public relations coordination.
• Gu previously led sales and marketing at Jiangsu Kaiqiang Medical Laboratory, later ran corporate affairs at Beijing Hightrust Diagnostics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CFCG - China First Capital Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260907-12323501), on September 07, 2026, and is solely responsible for the information contained therein.